Immunology: Current Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Immunol Curr Res 2023, Vol 7(3): 145
  • DOI: 10.4172/icr.1000145

The Janus-Faced Inflammasomes: Friend or Foe in Cancer

Dr. Matthew Wang*
Department of Health Sciences, The college of IITH, Hyderabad, India
*Corresponding Author : Dr. Matthew Wang, Department of Health Sciences, The college of IITH, Hyderabad, India, Email: wang@gmail.com

Received Date: May 01, 2023 / Accepted Date: May 28, 2023 / Published Date: May 29, 2023

Abstract

Cancer, a complex and multifactorial disease, continues to be a global health concern. Over the years, researchers have made significant strides in understanding the molecular mechanisms underlying cancer development and progression. Among these mechanisms, the inflammasome pathway has emerged as a fascinating area of investigation. Inflammasomes are multiprotein complexes that play a critical role in the regulation of inflammation and immunity. In recent years, mounting evidence has implicated inflammasomes in cancer, revealing their dual nature as both promoters and suppressors of tumorigenesis. This article aims to delve into the intricate relationship between inflammasomes and cancer, shedding light on their potential as therapeutic targets.

Citation: Wang M (2023) The Janus-Faced Inflammasomes: Friend or Foe inCancer. Immunol Curr Res, 7: 145. Doi: 10.4172/icr.1000145

Copyright: © 2023 Wang M. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top